Researchers have achieved a clean reversal of Type 1 diabetes in mice by rebuilding their immune systems and restoring ...

The U.S. Food and Drug Administration approved an Investigational New Drug (IND) application using efficacy data solely from ...

UCLA scientists have characterized the structure and function of a key survival protein in breast cancer cells that helps ...

Findings set the stage for further investigation of hSFRP2 mAb as a targeted therapy for triple-negative breast cancer.

The order of cancer-driving mutations—genetic changes—plays an important role in whether tumors in the intestine can develop, ...

Abstract: Skin Cancer is the most serious form of cancer, often spreading to other parts of the body over time. Early and accurate identification of skin lesions can improve the treatment options and ...

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows ...

GE HealthCare and the Mayo Clinic are expanding their long-running collaborative work to now include the development of new personalized radiation therapy approaches for cancer, with a pl | The ...

Sickle cell disease is associated with chronic oxidative stress, hemolysis, inflammation, and progressive multi--organ injury, including significant cardiopulmonary complications. Mitochondrial ...

The companies plan to test the treatment's efficacy in preclinical models of squamous cell lung carcinoma early next year.

CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform ...

Archaerhodopsin 3 (AR3) is a microbial proton pump that increases alkalinity inside a cell when exposed to green light.